TwinStrand Biosciences Overview
- Founded
- 2015

- Status
- Private
- Employees
- 38

- Latest Deal Type
- Series A
- Latest Deal Amount
- $16.3M

- Investors
- 8
TwinStrand Biosciences General Information
Description
Developer of a next-generation DNA sequencing therapy designed to detect ultra-rare variants of DNA molecules that are invisible by other sequencing approaches. The company's technique uses specialized adapters to uniquely tag both strands of individual DNA duplexes in a population, sequence and using proprietary software, read both strands of individual DNA molecules enabling researchers to get a new generation of high-accuracy clinical diagnostics and innovative tools for scientific discovery.
Contact Information
TwinStrand Biosciences Timeline
TwinStrand Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC (Series A) | 30-Dec-2019 | $16.3M | 000.00 | Completed | Generating Revenue | |
3. Grant | 01-Jan-2019 | 00.00 | 00.00 | Completed | Generating Revenue | |
2. Grant | 01-Jan-2018 | $2.3M | $6.1M | Completed | Generating Revenue | |
1. Seed Round | 13-Sep-2017 | $6.1M | $6.1M | 000.00 | Completed | Generating Revenue |
TwinStrand Biosciences Comparisons
Industry
0000000
000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialTwinStrand Biosciences Competitors (34)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Stratos Genomics | Formerly VC-backed | Seattle, WA | 00 | 000.00 | 000000&0 | 000.00 |
000000 | Venture Capital-Backed | Providence, RI | 00 | 0000 | 000000000 - | 0000 |
0000000 | Venture Capital-Backed | San Diego, CA | 000 | 00000 | 00000000000 | 00000 |
00000000000 | Corporate Backed or Acquired | Bothell, WA | 000000&0 | |||
00000000 0000000 0 | Formerly VC-backed | Castel Maggiore, Italy | 000 | 000.00 | 000000 - 000 |
TwinStrand Biosciences Executive Team (7)
TwinStrand Biosciences Board Members (11)
Name | Representing | Role | Since |
---|---|---|---|
Chad Waite Jr. | The W Fund | Chairman | 000 0000 |
Gary Gilliland MD | Self | Board Member | 000 0000 |
Jesse Salk Ph.D | TwinStrand Biosciences | Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member | 000 0000 |
Stephen Dow | Self | Board Member | 000 0000 |
Terry Myerson | TwinStrand Biosciences | Board Member | 000 0000 |
TwinStrand Biosciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTwinStrand Biosciences Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Madrona Venture Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
Ridgeback Capital | Other | Minority | 000 0000 | 000000 0 | |
Sahsen Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
National Institutes of Health | Government | 000 0000 | 000000 0 |